HEXALEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hexalen, and when can generic versions of Hexalen launch?
Hexalen is a drug marketed by Eisai Inc and is included in one NDA.
The generic ingredient in HEXALEN is altretamine. There is one drug master file entry for this compound. Additional details are available on the altretamine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEXALEN?
- What are the global sales for HEXALEN?
- What is Average Wholesale Price for HEXALEN?
Summary for HEXALEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 107 |
| Drug Prices: | Drug price information for HEXALEN |
| DailyMed Link: | HEXALEN at DailyMed |
US Patents and Regulatory Information for HEXALEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | HEXALEN | altretamine | CAPSULE;ORAL | 019926-001 | Dec 26, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
